Ken Griffin's position in Sage Therapeutics is currently worth $230 Thousand. That's 0.00% of their equity portfolio (3920th largest holding). The first Sage Therapeutics trade was made in Q3 2014. Since then Ken Griffin bought shares 63 more times and sold shares on 46 occasions. The investor's estimated purchase price is $2.14 Million, resulting in a loss of 89%.